Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Female and Male”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02634489
What this trial is testing

EC905 Pharmacokinetic Profile Study

Who this might be right for
Phase 1HealthyBenign Prostatic Hyperplasia+1 more
Astellas Pharma Europe B.V. 46
Early research (Phase 1)Study completedNCT03443063
What this trial is testing

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 16
Early research (Phase 1)Study completedNCT00863863
What this trial is testing

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Who this might be right for
Healthy
Actavis Inc. 40
Early research (Phase 1)Study completedNCT01189201
What this trial is testing

Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food

Who this might be right for
Healthy
Boehringer Ingelheim 42
Early research (Phase 1)Study completedNCT02963701
What this trial is testing

Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects

Who this might be right for
Healthy Volunteers
Boehringer Ingelheim 56
Early research (Phase 1)Study completedNCT06814119
What this trial is testing

A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

Who this might be right for
HealthyRenal Impairment
Merck Sharp & Dohme LLC 34
Early research (Phase 1)Study completedNCT01302028
What this trial is testing

Renal Impairment Study With ASP1941

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 40
Early research (Phase 1)Study completedNCT05492630
What this trial is testing

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects

Who this might be right for
Diabetic Nephropathy
Sunshine Lake Pharma Co., Ltd. 138
Early research (Phase 1)Study completedNCT02758171
What this trial is testing

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 56
Not applicableStudy completedNCT03339609
What this trial is testing

Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children

Who this might be right for
Lower Urinary Tract SymptomsUrologic Diseases
University Hospital, Ghent 83
Early research (Phase 1)Study completedNCT01129414
What this trial is testing

Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

Who this might be right for
Healthy
Sanofi 72
Early research (Phase 1)Study completedNCT01423721
What this trial is testing

Relative Bioavailability of Bromhexine Given as Granules and Syrup in Healthy Volunteers (Clinical Phase I Study)

Who this might be right for
Healthy
Boehringer Ingelheim 39
Early research (Phase 1)Study completedNCT02639221
What this trial is testing

A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects

Who this might be right for
Parkinson's Disease
Prexton Therapeutics 64
Not applicableStudy completedNCT02856633
What this trial is testing

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

Who this might be right for
Urinary Tract InfectionDiabetes MellitusAtrial Fibrillation+8 more
Cloud DX Inc. 40
Early research (Phase 1)Study completedNCT03220633
What this trial is testing

Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects

Who this might be right for
Chronic Pain
Antibe Therapeutics Inc. 84
Early research (Phase 1)Study completedNCT04260464
What this trial is testing

Renal Impairment Study of PF-06700841

Who this might be right for
Healthy VolunteerRenal Impairment
Pfizer 30
Early research (Phase 1)Study completedNCT02194348
What this trial is testing

Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 12
Not applicableNot Yet RecruitingNCT07305532
What this trial is testing

¹⁹F (Perfluoropropane) MRI

Who this might be right for
Healthy Volunteers - Male and Female
Alexei Ouriadov 200
Early research (Phase 1)Study completedNCT02171507
What this trial is testing

Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 24
Early research (Phase 1)WithdrawnNCT03545087
What this trial is testing

Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

Who this might be right for
Renal Insufficiency
Eli Lilly and Company
Next Page